Navigation Links
FDA Permits Marketing of a System to Repair Failed, Problematic Fix for Aortic Aneurysms
Date:11/21/2011

SILVER SPRING, Md., Nov. 21, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA's action will provide surgeons with a minimally-invasive option for repair of aortic endografts (endovascular grafts) that are not properly positioned. Aortic aneurysms can, over time, become weak and result in a life-threatening rupture. The endograft is placed inside the aorta to seal off the aneurysm and direct blood away from it.

The Aptus EndoStapling System is a cassette of nickel-cobalt corkscrew-shaped staples that is loaded into a long, thin, tube-like delivery catheter. The catheter is inserted into an artery in the leg and directed through the arteries to the failed endograft. Using a controller on the handle of the catheter, the surgeon applies one staple at a time around the top edge of the endograft to anchor the device and repair the endograft-artery seal.

"Leakage between the top end of the endograft and the aorta wall is a known complication of endograft implants that can be successfully treated," said Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health. "The Aptus EndoStapling System provides a less invasive option than open surgery to access and repair these leaks."

The FDA reviewed data for the Aptus EndoStapling System through the de novo reclassification process, a regulatory pathway for low- to moderate-risk medical devices that are novel and not comparable to an already legally marketed device.  

FDA granted the de novo petition for the EndoStapling System based on r
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Permits Marketing of First Test to Help Diagnose Dengue Fever
2. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
3. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
6. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
7. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
10. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
11. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Avizia, Inc., a leading provider of cutting-edge ... equity financing round led by NextGen Angels along with ... will be used to continue to fuel the rapidly ... Edward Kennedy , CEO and president of Tollgrade ... Leonard Kurtzman , CFO of newBrandAnalytics, who joined the ...
(Date:8/19/2014)... , Aug. 19, 2014  Cardiva Medical, Inc. ... tranches of a $16.5 million Series 3 private equity ... GE Capital. The Company will use the proceeds of ... to expand commercial efforts for its VASCADE® Vascular Closure ... Investing in Series 3 private equity ...
(Date:8/19/2014)... August 19, 2014 Oramed ... clinical-stage pharmaceutical company focused on the development of ... Intellectual Property Department of Spain ... invention, titled "Methods and Compositions for Oral Administrations ... Oramed Pharmaceuticals is a technology pioneer in ...
Breaking Medicine Technology:Avizia Closes Funding Round 2Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2Oramed Granted Patent in Spain for Oral Administration of Insulin 2Oramed Granted Patent in Spain for Oral Administration of Insulin 3
... May 2, 2011 EMBEDDED SYSTEMS CONFERENCE -- Samplify ... availability of Prism FP ™ , the first compression ... floating point data types.   "Distribution of ... of thousands of computing nodes poses a challenge in ...
... May 2, 2011 Prometheus Laboratories Inc., a specialty ... signed an exclusive agreement with WILEX AG for commercialization ... is a Phase III product candidate for adjuvant use ... Under the terms of the agreement, WILEX will receive ...
Cached Medicine Technology:Samplify Systems Announces Availability of Prism FP Floating Point Compression 2Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX® 2Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX® 3
(Date:8/20/2014)... “Have you recently been involved in an auto ... lawyer serving the greater Seattle area. “Are you still feeling ... keep reading . , In a recently released article, Dax ... accident can use to see if they may qualify for ... insurance claim will allow an individual to receive medical treatment ...
(Date:8/20/2014)... Springs, California (PRWEB) August 20, 2014 ... , designed the innovative RevitaDERM® Psoriasis Treatment ... that is associated with psoriasis. This all-in-one product ... symptoms. , RevitaDERM® Psoriasis Treatment is powered by ... odor commonly associated with this effective ingredient. ...
(Date:8/20/2014)... they often have difficulty falling asleep and staying asleep, ... In individuals with Alzheimer,s disease, this common and troubling ... leading to nighttime confusion and wandering. , Now, a ... Center (BIDMC) and the University of Toronto/Sunnybrook Health Sciences ... age. Reported online today in the journal Brain ...
(Date:8/20/2014)... GBK, the luxury lifestyle gift lounge and special events ... at the annual GBK Gift Lounge. This year’s event will ... from 11am – 6pm. GBK will offer guests an opportunity ... , As always, GBK will blend this award show celebration ... lounge. GO Campaign is a grantmaking organization that improves the ...
(Date:8/20/2014)... Kowa Optimed returns after a short ... the new SL-17 portable slit lamp. , The SL-17 ... source controlled by an illuminated thumb wheel for easy ... commercially available AAA rechargeable and dry cell batteries, which ... batteries designed specifically for the device. The new Sl-17 ...
Breaking Medicine News(10 mins):Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2
... source for correct information about Sex, according to a new ... in the study, conducted by the Canadian Association for Health ... disseminator about ‘Birds and The Bees’. Of course, teens also ... schools and discussion amongst friends. ,"One of ...
... flu in northwestern Germany has been steadily increasing over the ... of the 103 cases were identified outside the Baltic Sea ... been involved in collection of carcasses. ,Recently, nearly ... virus. The Institute for Animal Health in Riems had identified ...
... is on high alert to tackle any Bird Flu cases. ... of Medical Sciences (AIIMS)' and another 20// bedded ward has ... treat any of the patients with avian influenza or bird ... been the instruction to food restaurant in the city to ...
... news that that bird flu was found in chickens in a village ... change has affected Leong Hup, Farm's Best and CAB// Cakaran stockers the ... while Farm's Best shares and warrants lost 55 sen and 19.5 sen ... RM1.08. ,Among other poultry stocks, Lay Hong was ...
... Donald’s fried in another controversy which pertains to its French ... in United States over its use of wheat and milk ... contention is that these constituents might trigger allergy in some ... trans fat in a large serving of fries is higher ...
... doubts about consumption of chicken in Punjab, commonly known as ... chicken has already dropped by 30-50% over the past three ... tikka butter masala, rated as the most popular dish in ... for the past five years. Sadly, there has now been ...
Cached Medicine News:
... versatile new test providing the broadest range ... The Multi-Target Stereo test can be used ... stereopsis, visual attention, form and depth perception, ... includes a pair of high quality reversible ...
... stereo tests provide accurate measurement of ... choice of polarized glasses. The original ... slipped into a thin plastic frame ... includes Richmonds new P/N 4465 Polycarbonate ...
Comes with seven test plates. Red and green glasses filters are mounted in two frames, one for adults and one for children. Suitable for testing very small children as well as adults....
Lumicon 48 mm red filter....
Medicine Products: